As of 2025-09-15, the Fair Value of Regenxbio Inc (RGNX) is -17.38 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.20 USD, the upside of Regenxbio Inc is -288.91%.
With the market price of 9.20 USD and our fair value calculation, Regenxbio Inc (RGNX) is not a good investment. Investing in RGNX stocks now will result in a potential loss of 288.91%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -111.30 | 127.80 | -280.30 | -263.49 | -227.10 | -150.88 |
| YoY growth | -17.53% | 214.82% | -319.33% | 6.00% | 13.81% | -20.44% |
| Market Cap (mil) | 464.69 |
| P/E | |
| Forward P/E |
| EPS | -3.48 |
| Avg earnings growth rate | -20.44% |
| TTM earnings | -175.57 |